| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 31 |
| 1 | METHOTREXATE | 24 |
| 2 | METHOTREXATE SODIUM | 24 |
| 3 | CYCLOPHOSPHAMIDE | 23 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 23 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 23 |
| 6 | VEDOLIZUMAB | 17 |
| 7 | AZACITIDINE | 12 |
| 8 | INFLIXIMAB | 12 |
| 9 | PREDNISONE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM ACETATE | 1 | 0.0035 |
| 1 | INFLIXIMAB-DYYB | 6 | 0.0017 |
| 2 | BODY CLEANSER | 1 | 0.0014 |
| 3 | DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE | 1 | 0.0011 |
| 4 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 5 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 2 | 0.0008 |
| 6 | FERRIC DERISOMALTOSE | 1 | 0.0007 |
| 7 | DECITABINE | 3 | 0.0007 |
| 8 | GANCICLOVIR SODIUM | 6 | 0.0006 |
| 9 | ECALLANTIDE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 37 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 35 |
| 2 | Alkylating Drug [EPC] | 27 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 25 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 23 |
| 5 | Azole Antifungal [EPC] | 17 |
| 6 | Integrin Receptor Antagonist [EPC] | 17 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 8 | Platinum-based Drug [EPC] | 13 |
| 9 | BCL-2 Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0008 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Recombinant Human Growth Hormone [EPC] | 7 | 0.0003 |
| 3 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 5 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 6 | Asparagine-specific Enzyme [EPC] | 3 | 0.0002 |
| 7 | Integrin Receptor Antagonist [EPC] | 17 | 0.0002 |
| 8 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |
| 9 | Osmotic Diuretic [EPC] | 1 | 0.0002 |